Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1958 3
1959 1
1961 1
1964 1
1965 2
1966 2
1967 1
1968 3
1970 2
1971 1
1972 4
1973 3
1974 2
1975 3
1976 2
1977 4
1978 2
1979 4
1980 4
1981 6
1982 6
1983 7
1984 11
1985 7
1986 11
1987 8
1988 8
1989 19
1990 12
1991 15
1992 14
1993 25
1994 24
1995 28
1996 40
1997 36
1998 44
1999 45
2000 43
2001 43
2002 72
2003 93
2004 121
2005 148
2006 153
2007 192
2008 224
2009 270
2010 321
2011 347
2012 431
2013 492
2014 634
2015 659
2016 670
2017 758
2018 809
2019 948
2020 1109
2021 1283
2022 1493
2023 1339
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

11,778 results

Results by year

Filters applied: . Clear all
Page 1
Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial.
Chen HS, Cui Y, Zhou ZH, Zhang H, Wang LX, Wang WZ, Shen LY, Guo LY, Wang EQ, Wang RX, Han J, Dong YL, Li J, Lin YZ, Yang QC, Zhang L, Li JY, Wang J, Xia L, Ma GB, Lu J, Jiang CH, Huang SM, Wan LS, Piao XY, Li Z, Li YS, Yang KH, Wang DL, Nguyen TN; ARAMIS Investigators. Chen HS, et al. Among authors: shen ly. JAMA. 2023 Jun 27;329(24):2135-2144. doi: 10.1001/jama.2023.7827. JAMA. 2023. PMID: 37367978 Clinical Trial.
Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial.
Shah MA, Shitara K, Ajani JA, Bang YJ, Enzinger P, Ilson D, Lordick F, Van Cutsem E, Gallego Plazas J, Huang J, Shen L, Oh SC, Sunpaweravong P, Soo Hoo HF, Turk HM, Oh M, Park JW, Moran D, Bhattacharya P, Arozullah A, Xu RH. Shah MA, et al. Among authors: shen l. Nat Med. 2023 Aug;29(8):2133-2141. doi: 10.1038/s41591-023-02465-7. Epub 2023 Jul 31. Nat Med. 2023. PMID: 37524953 Free PMC article. Clinical Trial.
In Reply.
Castillejos AG, Devlin J, Saini C, Sun JA, Wang M, Johnson G, Chodosh J, Shen LQ. Castillejos AG, et al. Among authors: shen lq. Ophthalmol Glaucoma. 2023 Nov 4:S2589-4196(23)00196-5. doi: 10.1016/j.ogla.2023.11.001. Online ahead of print. Ophthalmol Glaucoma. 2023. PMID: 37931684 No abstract available.
Multi-omics blood atlas reveals unique features of immune and platelet responses to SARS-CoV-2 Omicron breakthrough infection.
Wang H, Liu C, Xie X, Niu M, Wang Y, Cheng X, Zhang B, Zhang D, Liu M, Sun R, Ma Y, Ma S, Wang H, Zhu G, Lu Y, Huang B, Su P, Chen X, Zhao J, Wang H, Shen L, Fu L, Huang Q, Yang Y, Wang H, Wu C, Ge W, Chen C, Huo Q, Wang Q, Wang Y, Geng L, Xie Y, Xie Y, Liu L, Qi J, Chen H, Wu J, Jiang E, Jiang W, Wang X, Shen Z, Guo T, Zhou J, Zhu P, Cheng T. Wang H, et al. Among authors: shen l. Immunity. 2023 Jun 13;56(6):1410-1428.e8. doi: 10.1016/j.immuni.2023.05.007. Epub 2023 May 16. Immunity. 2023. PMID: 37257450 Free PMC article.
Ferromagnetic transition-metal dopedɛ-phosphorene.
Wang Z, Wu Q, Shen L. Wang Z, et al. Among authors: shen l. J Phys Condens Matter. 2023 Jul 13;35(41). doi: 10.1088/1361-648X/ace40f. J Phys Condens Matter. 2023. PMID: 37402378
New treatment for osteoarthritis: Gene therapy.
Li X, Shen L, Deng Z, Huang Z. Li X, et al. Among authors: shen l. Precis Clin Med. 2023 May 30;6(2):pbad014. doi: 10.1093/pcmedi/pbad014. eCollection 2023 Jun. Precis Clin Med. 2023. PMID: 37333626 Free PMC article. Review.
Managing osteoporosis in COPD.
Shen L, Lv J, Li J, Zhou J, Wang X. Shen L, et al. Endocr Metab Immune Disord Drug Targets. 2023 Sep 13. doi: 10.2174/1871530323666230913105752. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 37711118
11,778 results
You have reached the last available page of results. Please see the User Guide for more information.